Clinical
Benchmarks’ USDA clinical and FDA pre-clinical expertise is focused on licensing our client’s products or maintaining/clarifying existing product life cycles. Necessary facilities are in place to house surrogate models for small target or laboratory species in-house. Larger surrogate or target species are managed by our personnel at off-site locations.
Benchmark’s Clinical Services include:
- Immunogenicity
- Safety and Challenge
- Hyperimmunization for Antibody Production
- Tissue and Immune-Cell Isolation.
- Animal Model Development (Target or Surrogate),
- Product Development
- Novel Sampling Methods and Analytic Testing
- Reduction
- Refinement
- Replacement
- Novel Sampling Methods and Analytic Testing
- Serum- and Antibody-Response Assays Proof of Concept
- Efficacy/Immunogenicity (i.e. Minimum Immunizing Dose)
- Specialized Reagent Production
- Interference
- Vaccine Safety (Target and Surrogate Animal)
- Field Safety
- Data Capture
- Flow Cytometry
- CMI Bioassays
- PCR Cytokine Cascades
- Innate-Response Assays
- Mucosal-Response Assays
- Final Report Generation